Latest Breaking News On - Marinus pharmaceuticals trading - Page 1 : comparemela.com

Marinus Pharmaceuticals (MRNS) Set to Announce Earnings on Wednesday

Marinus Pharmaceuticals (MRNS) Set to Announce Earnings on Wednesday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdMarinus pharmaceuticals incCantor fitzgeraldNews ratings for marinus pharmaceuticals dailyMarinus pharmaceuticals tradingMarinus pharmaceuticalsEarnings history for marinus pharmaceuticalsRoyal bankGet free reportMarinus pharmaceuticals daily

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Lowered to $11 00 at HC Wainwright

Marinus Pharmaceuticals (NASDAQ:MRNS) Price Target Lowered to $11 00 at HC Wainwright
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdCantor fitzgeraldMarinus pharmaceuticalsMarinus pharmaceuticals company profileRoyal bankSg americas securitiesInstitutional trading of marinus pharmaceuticalsAnalyst recommendations for marinus pharmaceuticalsNews ratings for marinus pharmaceuticals dailyChina universal asset management coSherbrooke park advisersMarinus pharmaceuticals tradingMarinus pharmaceuticals incAcuta capital partnersGet free reportUniversal asset management

HC Wainwright Reiterates Buy Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)

HC Wainwright Reiterates Buy Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hedge funds weigh in on marinus pharmaceuticalsCharles schwab investment management incGoldman sachs group incMarinus pharmaceuticals tradingAnalyst recommendations for marinus pharmaceuticalsRoyal bankRenaissance technologiesMarinus pharmaceuticals incNews ratings for marinus pharmaceuticals dailyMetlife investment managementMarinus pharmaceuticalsGet free reportLife investment managementSchwab investment managementSachs groupQuantbot technologies

Marinus Pharmaceuticals (MRNS) Outperform Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $24.00 target price on the biopharmaceutical company’s stock. A number of other research analysts have also recently commented on the stock. Truist Financial cut […]

Institutional trading of marinus pharmaceuticalsMarinus pharmaceuticals incAmeritas investment partners incMarinus pharmaceuticals tradingMarinus pharmaceuticalsRoyal bankAnalyst recommendations for marinus pharmaceuticalsNews ratings for marinus pharmaceuticals dailyBluepath capital managementLife insurance coMarinus pharmaceuticals company profileFree reportModerate buyGet free reportPath capital managementAmeritas investment partners

228,714 Shares in Marinus Pharmaceuticals, Inc (NASDAQ:MRNS) Acquired by Altium Capital Management LP

Altium Capital Management LP acquired a new stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 228,714 shares of the biopharmaceutical company’s stock, valued at approximately $1,578,000. Altium Capital Management LP owned about 0.45% of Marinus […]

Scott braunsteinSteven pfanstielMarinus pharmaceuticalsDenali advisorsNews ratings for marinus pharmaceuticals dailyQuarter for marinus pharmaceuticalsMarinus pharmaceuticals tradingMarinus pharmaceuticals incSecurities exchange commissionMarinus pharmaceuticals company profileAltium capital managementFree reportCapital managementStreet groupGet free reportExchange commission